is the glp 1 shortage over FDA ends GLP-1 shortage. Compounding loophole closing. See pricing & supply data in our report: https://glp-1.reviews/2026-global-glp-1 -industry-statistics-the-definitive-data-report-on-pricing-supply-and-provider-integrity/ #GLP1 #FDA #HealthUpdate How GLP-1s Broke Healthcare Distribution

It is this rapid expansionwhich has persisted even after GLP-1s were removed from the FDA drug shortage listthat prompted the introduction of the SAFE Drugs Act and has simultaneously driven heightened FDA oversight

In a state where the obesity rate ranks among the highest in the country, many health providers were thrilled when Mississippi Medicaid in 2023 began covering GLP-1s for people 12 and older

Minimum between doses: 48 hours Flexibility window: Up to 2 days early or 2 days late Missed dose window: 5 days (Ozempic), varies (Wegovy) One day early risk level: Very low If you are using compounded semaglutide , the same timing rules apply

While more than half of adults across partisans say Medicare should cover the cost of these drugs for weight loss, Democrats (66%) are somewhat more likely than Republicans (55%) to say this